PMID- 17008547 OWN - NLM STAT- MEDLINE DCOM- 20070830 LR - 20220311 IS - 0006-4971 (Print) IS - 1528-0020 (Electronic) IS - 0006-4971 (Linking) VI - 109 IP - 2 DP - 2007 Jan 15 TI - Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. PG - 653-60 AB - Dendritic cells (DCs) play a key role in immune homeostasis and maintenance of self-tolerance. Tolerogenic DCs can be established by an encounter with apoptotic cells (ACs) and subsequent inhibition of maturation and effector functions. The receptor(s) and signaling pathway(s) involved in AC-induced inhibition of DCs have yet to be defined. We demonstrate that pretreatment with apoptotic but not necrotic cells inhibits activation of IkappaB kinase (IKK) and downstream NF-kappaB. Notably, receptor tyrosine kinase Mer (MerTK) binding of ACs is required for mediating this effect. Monocyte-derived DCs lacking MerTK expression (MerTKKD) or treated with blocking MerTK-specific antibodies (Abs) are resistant to AC-induced inhibition and continue to activate NF-kappaB and secrete proinflammatory cytokines. Blocking MerTK activation of the phosphatidylinositol 3-kinase (PI3K)/AKT pathway prevents AC-induced inhibition. These results demonstrate an essential role for MerTK-mediated regulation of the PI3K/AKT and NF-kappaB pathways in AC-induced inhibition of monocyte-derived DCs. FAU - Sen, Pradip AU - Sen P AD - Department of Microbiology and Immunology, Mary Ellen Jones Bldg, Rm 804, Campus Box 7290, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599-7290, USA. FAU - Wallet, Mark A AU - Wallet MA FAU - Yi, Zuoan AU - Yi Z FAU - Huang, Yingsu AU - Huang Y FAU - Henderson, Michael AU - Henderson M FAU - Mathews, Clayton E AU - Mathews CE FAU - Earp, H Shelton AU - Earp HS FAU - Matsushima, Glenn AU - Matsushima G FAU - Baldwin, Albert S Jr AU - Baldwin AS Jr FAU - Tisch, Roland M AU - Tisch RM LA - eng GR - P60 DE013079/DE/NIDCR NIH HHS/United States GR - R37 AI035098/AI/NIAID NIH HHS/United States GR - AI066075/AI/NIAID NIH HHS/United States GR - AI35098/AI/NIAID NIH HHS/United States GR - R01 AI050736/AI/NIAID NIH HHS/United States GR - R01 AI066075/AI/NIAID NIH HHS/United States GR - 1-P60-DE 13079/DE/NIDCR NIH HHS/United States GR - U19 AI056374/AI/NIAID NIH HHS/United States GR - AI056374/AI/NIAID NIH HHS/United States GR - AI50736/AI/NIAID NIH HHS/United States GR - R01 AI035098/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20060928 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Antibodies) RN - 0 (NF-kappa B) RN - 0 (Proto-Oncogene Proteins) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) RN - EC 2.7.10.1 (Mertk protein, mouse) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) RN - EC 2.7.10.1 (c-Mer Tyrosine Kinase) SB - IM MH - Animals MH - Antibodies/immunology MH - Apoptosis/*immunology MH - Cells, Cultured MH - Dendritic Cells/*immunology MH - Female MH - Male MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Mice, Inbred NOD MH - Mice, Knockout MH - NF-kappa B/*metabolism MH - Phosphatidylinositol 3-Kinases/immunology MH - Proto-Oncogene Proteins/*immunology MH - Receptor Protein-Tyrosine Kinases/*immunology MH - Signal Transduction/immunology MH - c-Mer Tyrosine Kinase PMC - PMC1785106 COIS- Conflict-of-interest disclosure: The authors declare no competing financial interests. EDAT- 2006/09/30 09:00 MHDA- 2007/08/31 09:00 PMCR- 2008/01/15 CRDT- 2006/09/30 09:00 PHST- 2006/09/30 09:00 [pubmed] PHST- 2007/08/31 09:00 [medline] PHST- 2006/09/30 09:00 [entrez] PHST- 2008/01/15 00:00 [pmc-release] AID - S0006-4971(20)52076-4 [pii] AID - 2006/017368 [pii] AID - 10.1182/blood-2006-04-017368 [doi] PST - ppublish SO - Blood. 2007 Jan 15;109(2):653-60. doi: 10.1182/blood-2006-04-017368. Epub 2006 Sep 28.